Chronic Losartan treatment blocks isoproterenol-induced dipsogenesis

Abstract

Previous studies suggest that beta-adrenergic receptor agonists and other hypotensive agents stimulate water intake via the renin-angiotensin system (RAS). However, a recent study reported that acute peripheral administration of Losartan, an angiotensin II (All) type I receptor antagonist, failed to inhibit isoproterenol-induced water intake. In the current study we assessed the role of chronic Losartan treatment on isoproterenol-induced water intake. Male Sprague-Dawley rats were divided into two groups ( n = 10/group). The experimental group was chronically treated with Losartan in the drinking water (120 mg/kg/day). Rats in the control group were maintained on normal tap water. At the end of each week, water intake in response to isoproterenol was determined. On the days of the dipsogenic study, water intake was determined 1 h prior to and 2 h following SC injection of isoproterenol (25 μg/kg). isoproterenol-induced water intake in the experimental group was significantly lower than the control rats by 71 % and 88% at the end of weeks one and two respectively ( p < 0.01). Following ten days of Losartan treatment, dipsogenic response to All likewise demonstrated a complete blockage of All receptors (75% decrease compared to the controls). These data strongly suggest that water intake in response to isoproterenol is mediated in part by the RAS.